NEW CLINICAL STUDY SHOWS DOUBLING IN RESPONSE RATE AND LONGEVITY IN PATIENTS WITH ADVANCED LUNG CANCER USING PERSONALIZED TREATMENT FOR LUNG CANCER COMES OF AGE Essentially what this study shows is that by using certain methods of testing which chemo … Continue reading →